uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
15.38
-0.92 (-5.64%)
At close: Apr 10, 2026, 4:00 PM EDT
15.52
+0.14 (0.91%)
After-hours: Apr 10, 2026, 7:59 PM EDT
uniQure Market Cap
uniQure has a market cap or net worth of $961.7 million as of April 10, 2026. Its market cap has increased by 30.29% in one year.
Market Cap
961.70M
Enterprise Value
875.75M
1-Year Change
30.29%
Ranking
Category
Stock Price
$15.38
Market Cap Chart
Since March 15, 2017, uniQure's market cap has increased from $161.10M to $961.70M, an increase of 496.96%. That is a compound annual growth rate of 21.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 961.70M | -35.48% |
| Dec 31, 2025 | 1.49B | 73.16% |
| Dec 31, 2024 | 860.80M | 165.93% |
| Dec 29, 2023 | 323.70M | -69.50% |
| Dec 30, 2022 | 1.06B | 10.73% |
| Dec 31, 2021 | 958.50M | -40.38% |
| Dec 31, 2020 | 1.61B | -48.57% |
| Dec 31, 2019 | 3.13B | 190.93% |
| Dec 31, 2018 | 1.07B | 78.06% |
| Dec 29, 2017 | 603.40M | 274.55% |
| Mar 15, 2017 | 161.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inventiva | 1.01B |
| Xeris Biopharma Holdings | 1.01B |
| Phathom Pharmaceuticals | 1.00B |
| KalVista Pharmaceuticals | 993.20M |
| GH Research | 975.10M |
| CytomX Therapeutics | 949.02M |
| Annexon | 938.77M |
| Aktis Oncology | 933.06M |